Clinically early-stage CSPα mutation carrier exhibits remarkable terminal stage neuronal pathology with minimal evidence of synaptic loss.
Benitez, Bruno A, Nigel J Cairns, Robert E Schmidt, John C Morris, Joanne B Norton, Carlos Cruchaga, and Mark S Sands. 2015. “Clinically Early-Stage CSPα Mutation Carrier Exhibits Remarkable Terminal Stage Neuronal Pathology With Minimal Evidence of Synaptic Loss.”. Acta Neuropathologica Communications 3: 73.